Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

BackgroundElectroencephalogram (EEG) is a promising, non-invasive method for identifying the presence of Alzheimer's disease (AD) by recognizing specific brain activity patterns associated with the disease. However, research on the correlation between EEG and the degree of cognitive impairment is still lacking.ObjectiveIn this study, we employ machine learning models to explore the potential of EEG in distinguishing different levels of cognitive impairment and various types of dementia.MethodsA total of 431 participants, including 77 cognitively unimpaired (CU), 167 patients with mild dementia, 110 patients with moderate dementia, and 77 patients with severe dementia were enrolled. Among them, 91 patients have detailed biomarker results to support differential diagnosis, with 77 AD and 14 frontotemporal dementia. After feature extraction, the rule-based representation learning was used to train models for EEG-based classification tasks.ResultsOur model can effectively differentiate between CU and moderate-to-severe dementia (AUC 0.8475), as well as between CU and AD patients in individuals under 65 (AUC 0.8170). However, our preliminary analysis was not able to effectively distinguish between different types of dementia. It is also challenging to differentiate between CU and mild dementia groups, as well as between the moderate and severe dementia.ConclusionsOur study suggests that EEG might be used not only in the early identification of AD, but also in the diagnosis and monitoring of the entire dementia spectrum, encompassing various stages and types of cognitive decline.

Download full-text PDF

Source
http://dx.doi.org/10.1177/13872877251360331DOI Listing

Publication Analysis

Top Keywords

dementia
9
machine learning
8
differential diagnosis
8
cognitive impairment
8
mild dementia
8
patients
5
application machine
4
learning eeg-based
4
eeg-based dementia
4
diagnosis
4

Similar Publications

Importance: It is unclear whether the duration of amyloid-β (Aβ) pathology is associated with neurodegeneration and whether this depends on the presence of tau.

Objective: To examine the association of longitudinal atrophy with Aβ positron emission tomography (PET)-positivity (Aβ+) and the estimated duration of Aβ+ (Aβ+ duration), controlling for tau-positivity.

Design, Setting, And Participants: Data for this longitudinal cohort study were drawn from the Wisconsin Registry for Alzheimer Prevention and the Wisconsin Alzheimer Disease Research Center Clinical Core Study.

View Article and Find Full Text PDF

Acute ischemic stroke (AIS) remains a leading cause of mortality and long-term disability globally, with survivors at high risk of recurrent stroke, cardiovascular events, and post-stroke dementia. Statins, while widely used for their lipid-lowering effects, also possess pleiotropic properties, including anti-inflammatory, endothelial-stabilizing, and neuroprotective actions, which may offer added benefit in AIS management. This article synthesizes emerging evidence on statins' dual mechanisms of action and evaluates their role in reducing recurrence, improving survival, and mitigating cognitive decline.

View Article and Find Full Text PDF

Exploring LRP-1 in the liver-brain axis: implications for Alzheimer's disease.

Mol Biol Rep

September 2025

Department of Pharmacology, Govt. College of Pharmacy, Rohru, Shimla, Himachal Pradesh, 171207, India.

Alzheimer's disease (AD) is the most common, complex, and untreatable form of dementia which is characterized by severe cognitive, motor, neuropsychiatric, and behavioural impairments. These symptoms severely reduce the quality of life for patients and impose a significant burden on caregivers. The existing therapies offer only symptomatic relief without addressing the underlying silent pathological progression.

View Article and Find Full Text PDF

Introduction: Age related hearing loss is in the top ten contributors to the global burden of disease and one of the largest modifiable risk factors for age-related dementia. However, awareness of the consequences of untreated hearing loss is poor and many adults do not seek hearing assessment. Despite World Health Organisation recommendations, no EU country currently has a national adult screening programme.

View Article and Find Full Text PDF

A new whole-body exposure facility for a randomized, double-blind, cross-over provocation study investigating possible effects of 50 Hz magnetic field exposure on sleep and markers of Alzheimer's disease has been developed and dosimetrically analyzed. The exposure facility was custom-tailored for the sleep laboratory where the study was carried out and enables magnetic flux densities of up to 30 μT with a maximum field inhomogeneity of less than ± 20%. Exposure is applied fully software-controlled and in a blinded and randomized manner.

View Article and Find Full Text PDF